What are the strategies for reducing drug attrition rates in the clinic through the application of transgenic rodent models?
22 February 2011
Company will provide open access to its rAAV GENESIS human gene-editing platform as part of strategy to generate 2500 new in vitro models of cancer, neurodegenerative cardiovascular and infectious diseases.
14 December 2010
Researchers have initially identified the neural pathways that control peace of mind in the human brain, which could lead to the development of new therapies in the treatment of anxiety disorders and depression.
03 November 2010
Researchers have shown that they might be able to monitor the aging process in the brain by using MRI to measure brain lactic acid levels.
02 November 2010
Researchers have created a draft genome sequence for the endangered Tasmanian devil and will use this to find genetic mutations in the transmissible cancer ravaging its population.
17 September 2010
Charles River Laboratories, a global preclinical contract research organization, now offers BlueScreen HC Screening services for the early detection of genotoxicity.
09 September 2010
The combined effects of numerous single-letter changes in several genes could be used to predict a woman’s risk of developing the most common form of breast cancer – oestrogen-receptor-positive breast cancer.
07 September 2010
Fear can make you run or fight, or it can glue you to the spot. Now, scientists have identified the part of the brain and the type of neurons that determine how mice react to a frightening stimulus.
31 August 2010
Researchers have used a drug to reset and restart the 24 hour body clock of mice, which could eventually help with human difficulties including some psychiatric disorders, jet lag and the health impacts of shift work.
24 August 2010
Researchers have made a discovery that could lead to a brand new class of drugs to treat chronic pain caused by inflammatory conditions, such as arthritis and back pain, without numbing the whole body.
18 August 2010